The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIO-PATH HOLDINGS INC | COM | 09057N102 | 4,406 | 3,830,882 | SH | SOLE | 0 | 3,830,882 | 0 | 0 | |
EQUIFAX INC. | COM | 294429105 | 3 | 29 | SH | SOLE | 0 | 29 | 0 | 0 | |
GENERAL MOLY INC | COM | 370373102 | 2,069 | 2,922,831 | SH | SOLE | 0 | 2,922,831 | 0 | 0 | |
INTREXON CORPORATION | COM | 46122T102 | 102,484 | 2,100,085 | SH | SOLE | 0 | 2,100,085 | 0 | 0 | |
INVESCO LTD | COM | G491BT108 | 187 | 5,000 | SH | SOLE | 0 | 5,000 | 0 | 0 | |
LEXICON PHARMACEUTICALS INC | COM | 528872302 | 287 | 35,714 | SH | SOLE | 0 | 35,714 | 0 | 0 | |
MOBILEYE | COM | N51488117 | 207 | 3,900 | SH | SOLE | 0 | 3,900 | 0 | 0 | |
PORTLAND GENERAL ELECTRIC CO | COM | 736508847 | 4 | 118 | SH | SOLE | 0 | 118 | 0 | 0 | |
SPDR GOLD TRUST | ETFS | 78463V107 | 1,726 | 15,361 | SH | SOLE | 0 | 15,361 | 0 | 0 | |
TEXAS INSTRUMENTS INC | COM | 882508104 | 1,648 | 32,000 | SH | SOLE | 0 | 32,000 | 0 | 0 | |
VANGUARD 500 INDEX FUND | ETFS | 922908363 | 3,101 | 16,421 | SH | SOLE | 0 | 16,421 | 0 | 0 | |
VANGUARD ENERGY ETF | ETFS | 92204A306 | 1,822 | 17,039 | SH | SOLE | 0 | 17,039 | 0 | 0 | |
VANGUARD FTSE DEV MKTS | ETFS | 921943858 | 2,585 | 65,204 | SH | SOLE | 0 | 65,204 | 0 | 0 | |
VANGUARD MID-CAP VALUE ETF | ETFS | 922908512 | 2,376 | 26,234 | SH | SOLE | 0 | 26,234 | 0 | 0 | |
VANGUARD MSCI EMERGING MKTS | ETFS | 922042858 | 2,475 | 60,541 | SH | SOLE | 0 | 60,541 | 0 | 0 | |
VANGUARD REIT ETF | ETFS | 922908553 | 1,377 | 18,431 | SH | SOLE | 0 | 18,431 | 0 | 0 | |
WILLIAMS PARTNERS LP | LP - PUBLIC EQUITY | 96949L105 | 8,365 | 172,732 | SH | SOLE | 0 | 172,732 | 0 | 0 | |
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 144,754 | 12,062,803 | SH | SOLE | 0 | 12,062,803 | 0 | 0 |